Biomedical Engineering Reference
In-Depth Information
28. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJM.
Exercise capacity and ventilatory, circulatory, and symptom limitation in
patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146:935-940.
29. Jones NL, Killian KJ. Mechanisms of disease: exercise limitation in health and
disease. N Engl J Med 2000; 343(9):632-641.
30. Gosker HR, Wouters EFM, Van der Vusse GJ, Schofs AMWJ. Skeletal
muscle dysfunction in COPD and chronic heart failure: underlying
mechanisms and therapy perspectives. Am J Clin Nutr 2000; 71:1033-1047.
31. Harper R, Brazier JE, Waterhouse JC, Walters SJ, Jones NM, Howard P.
Comparison of outcome measures for patients with chronic obstructive
pulmonary disease (COPD) in an outpatient setting. Thorax 1997; 52(10):
879-887.
32. Jones PW. Issues concerning health-related quality of life in COPD. Chest
1995; 107(suppl):187S-193S.
33. Goldstein RS, Gort EH, Stubbing D, Avendano MA, Guyatt GH. Rando-
mised controlled trial of
respiratory rehabilitation. Lancet 1994; 344:
1394-1397.
34. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary reha-
bilitation on physiologic and psychosocial outcomes in patients with chronic
obstructive pulmonary disease. Ann Intern Med 1995; 122:823-832.
35. Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS. Meta-ana-
lysis of respiratory rehabilitation in chronic obstructive pulmonary disease.
Lancet 1996; 348(9035):1115-1119.
36. Rennard S, Carrera M, Agusti AG. Management of chronic obstructive
pulmonary disease: are we going anywhere? Eur Respir J 2000; 16(6):1035-
1036.
37. Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, et
al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation:
a randomised controlled trial. Lancet 2000; 355(9201):362-368.
38. Reid MB. COPD as a muscle disease. Am J Respir Crit Care Med 2001;
164(7):1101-1102.
39. Debigare R, Cote CH, Maltais F. Peripheral muscle wasting in chronic
obstructive pulmonary disease. Clinical relevance and mechanisms. Am J
Respir Crit Care Med 2001; 164(9):1712-1717.
40. Agusti AGN, Barber´ JA. Chronic pulmonary diseases: chronic obstructive
pulmonary disease and idiopathic pulmonary fibrosis. Thorax 1994; 49:
924-932.
41. Vescovo G, Zennaro R, Sandri M, Carraro U, Leprotti C, Ceconi C, et al.
Apoptosis of skeletal muscle myofibers and interstitial cells in experimental
heart failure. J Mol Cell Cardiol 1998; 30(11):2449-2459.
42. Roca J, Whipp BJ, Agusti AGN, Anderson SD, Casaburi R, Cotes JE, et al.
ERS Task Force. Clinical exercise testing with reference to lung diseases: indi-
cations, standardization and interpretation strategies. Eur Respir J 1997;
10:2662-2689.
43. Roca J, Agusti AGN, Alonso A, Barber´ JA, Rodriguez-Roisin R, Wagner
PD. Effects of training on muscle O2 transport at VO2max. J Appl Physiol
1992; 73:1067-1076.
